G1 Therapeutics
G1 is a biopharmaceutical company that researches, develops, and commercializes gene therapies for the treatment of cancer.
Business Model:
Revenue: $46.8M
Employees: 51-200
Industries / Tags:
Detailed G1 Therapeutics Information
Geographic Data
Address: 700 Park Offices Drive
City: Research Triangle Park
State: NC
Zip: 27709
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$100M
Raised Total:$349M
Social
Metrics
2,037,200Website Global Rank
10,077Website Monthly Traffic
Twitter Followers
Description
G1 is a biopharmaceutical company that researches, develops, and commercializes gene therapies for the treatment of cancer.
Contact Phone:
+19192139835
Contact Email:
G1 Therapeutics went public on 5/16/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/16/2017
IPO Valuation:
$400M
Ticker Symbol:
GTHX
IPO Price:
$15/share
Amount Raised:
$105M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
